PRHB Pure H2O Bio Technologies Inc New (CE)

Please replace the release dated Nov. 4, 2008 with the following corrected version due to multiple revisions. The corrected release reads: PURE H2O BIO-TECHNOLOGIES, INC., ANNOUNCES RELEASE OF A NEW INFORMATIONAL VIDEO Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announced today the release of its new informational video and transcript detailing the Company�s Silver-TTOTM (tetrasilver tetraoxide) technology. The PRHB Silver-TTOTM technology can now be viewed as very competitive and a significant improvement over all current water treatment products from a business development perspective. The video can be viewed on the Company�s web-site at www.pureh20biotech.com. You can also visit our video at www.jerryvconsulting.com. Additional sites will be forthcoming. Silver-TTO� Water Disinfection of Resistant Cryptosporidium Market Opportunity � Treatment of Emerging Water-Borne Disease Pathogens Over the past 20-years, increasing demands for pure drinking water by hospitals, clinics, nursing homes, residential consumers as well as recreational, educational, military, and commercial facilities have generated the need for water treatment technology that can disinfect organisms that are refractory to conventional water treatment and filtration. 286 million people in the US receive their water from public drinking water systems. In 2007, the EPA determined that over 51,252 or 32.9% of the drinking water systems in the US reported at least one health-based standard, monitoring and reporting, or other violation. Moreover, there is an additional need for the 5,747 registered hospitals in the US to provide safe drinking water in the heath care delivery setting. International opportunities are also another market sector particularly in developing countries. Pure H20 Bio-Technologies, Inc., intends to leverage its novel Silver TTO� disinfection technology to produce water treatment systems that effectively treat chlorine-resistant water-borne pathogens such as Cryptosporidium and related enteric bacteria. The proprietary Silver TTO� technology has the potential to disrupt the existing water treatment market in commercial, institutional as well as residential market sectors. PRHB is currently working with several marketing firms to assist the Company in its effort to provide additional exposure regarding its Silver-TTOTM technology to a broader market including, but not limited to, the medical industry. "We believe this video effectively represents that our Silver TTOTM disinfectant is far superior over the current technologies", stated Joseph Doxey, CEO of Pure H20 Bio-Technologies, Inc. About Pure H20 Bio-Technologies, Inc.: Pure H20 Bio-Technologies, Inc. (PRHB) is a publicly held company specializing in the manufacturing, design, and sale of its unique residential, commercial and hospital point-of-use potable water disinfection systems. These systems are specifically designed to work effectively against water-borne pathogens and remove heavy metals and objectionable biomasses. The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," "potential,""suggests," "may," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations regarding future research, development, and/or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and completion in general. Forward-looking statements speak only as to the date they were made. The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.